Chemed (NYSE:CHE) Hits New 52-Week High - Here's Why

Key Points

• Chemed reached a new 52-week high, trading as high as $519.05 and last changing hands near $514.94, up from its prior close of $509.34.
• Analyst sentiment remains cautious: the stock has a consensus “Hold” rating from six analysts, with a consensus price target of $480.25—below its current trading level.
• Chemed pays a quarterly dividend of $0.60, or $2.40 annually, representing a 0.5% yield; insiders recently sold shares, while institutional investors own approximately 95.85% of the company.

Chemed Corporation (NYSE:CHE - Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $519.05 and last traded at $514.9440, with a volume of 3626 shares. The stock had previously closed at $509.34.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CHE. Bank of America increased their price target on Chemed from $450.00 to $510.00 and gave the stock a "neutral" rating in a report on Thursday, July 9th. Weiss Ratings upgraded shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Royal Bank Of Canada boosted their target price on shares of Chemed from $422.00 to $436.00 and gave the company a "sector perform" rating in a research report on Monday, April 27th. Zacks Research raised shares of Chemed from a "strong sell" rating to a "hold" rating in a research note on Monday, April 27th. Finally, Wall Street Zen cut shares of Chemed from a "buy" rating to a "hold" rating in a report on Monday, June 8th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $480.25.

Chemed Trading Up 0.9%

The firm has a fifty day simple moving average of $459.92 and a 200-day simple moving average of $434.09. The firm has a market cap of $6.82 billion, a P/E ratio of 27.99, a price-to-earnings-growth ratio of 1.88 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed's dividend payout ratio (DPR) is currently 13.08%.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the firm's stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 3.33% of the company's stock.

Institutional Investors Weigh In On Chemed

Institutional investors and hedge funds have recently made changes to their positions in the business. Monetary Solutions Ltd acquired a new position in Chemed during the 4th quarter valued at about $25,000. Los Angeles Capital Management LLC purchased a new stake in shares of Chemed in the fourth quarter worth approximately $26,000. BOK Financial Private Wealth Inc. bought a new position in shares of Chemed in the fourth quarter valued at approximately $27,000. Versant Capital Management Inc boosted its position in shares of Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company's stock valued at $35,000 after buying an additional 75 shares during the last quarter. Finally, Global Retirement Partners LLC boosted its position in shares of Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company's stock valued at $37,000 after buying an additional 58 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.